BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14648708)

  • 1. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
    Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
    Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
    Conzelmann M; Dieterle CP; Linnemann U; Berger MR
    Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
    Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
    Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.
    Rosenberg R; Hoos A; Mueller J; Nekarda H
    Br J Cancer; 2000 Nov; 83(10):1323-9. PubMed ID: 11044357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
    Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
    Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.
    Kong SL; Salto-Tellez M; Leong AP; Chan YH; Koay ES
    J Clin Pathol; 2005 Aug; 58(8):839-44. PubMed ID: 16049286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
    Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
    Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
    Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
    Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.
    Ho SB; Hyslop A; Albrecht R; Jacobson A; Spencer M; Rothenberger DA; Niehans GA; D'Cunha J; Kratzke RA
    Clin Cancer Res; 2004 Sep; 10(17):5777-84. PubMed ID: 15355906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.
    Futamura M; Takagi Y; Koumura H; Kida H; Tanemura H; Shimokawa K; Saji S
    J Surg Oncol; 1998 May; 68(1):34-40. PubMed ID: 9610661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of detecting lymph node micrometastasis of colorectal cancer by reverse transcriptase-polymerase chain reaction (RT-PCR)].
    Yuan HY; Cheng FL; Wei ZZ; Yang GL; Chen JK
    Ai Zheng; 2004 Sep; 23(9):1069-73. PubMed ID: 15363204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.
    Schuster R; Max N; Mann B; Heufelder K; Thilo F; Gröne J; Rokos F; Buhr HJ; Thiel E; Keilholz U
    Int J Cancer; 2004 Jan; 108(2):219-27. PubMed ID: 14639606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
    Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
    Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
    Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
    J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer. effect of individual markers and tissue samples.
    Salto-Tellez M; Kong SL; Leong AP; Koay ES
    Eur J Cancer; 2003 Jun; 39(9):1234-41. PubMed ID: 12763211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.